Humedix Co., Ltd. logo

Humedix Co., Ltd. (200670)

Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM
₩
23,200. 00
-1,250
-5.1125%
₩
463.12B Market Cap
- P/E Ratio
2,280% Div Yield
30,299 Volume
- Eps
₩ 24,450
Previous Close
Add Transaction
Day Range
22,950 23,950
Year Range
21,050 52,700
Want to track 200670 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

200670 closed today lower at ₩23,200, a decrease of -5.1125% from yesterday's close, completing a monthly decrease of -6.0729% or -₩1,500. Over the past 12 months, 200670 stock lost -42.5031%.
200670 pays dividends to its shareholders, with the most recent payment made on Sep 16, 2026. The next estimated payment will be in In 2 months on Dec 16, 2026 for a total of ₩200.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Humedix Co., Ltd. has completed 5 stock splits, with the recent split occurring on Dec 27, 2018.
The company's stock is traded on one exchange.

200670 Chart

People also search for

Hyundai Motor Co.
₩ 295,500
-5.7416%
Hyundai Motor Co. Ltd.
₩ 151,800
-5.2434%
Hyundai Motor Co. Ltd. Preferred
₩ 152,400
-5.984%
Hyundai Motor Co., Ltd. Preferred
₩ 153,700
-5.2404%
Kia Corporation
₩ 105,900
-2.4862%

Humedix Co., Ltd. (200670) FAQ

What is the stock price today?

The current price is ₩23,200.00.

On which exchange is it traded?

Humedix Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 200670.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2,280%.

What is its market cap?

As of today, the market cap is 463.12B.

Has Humedix Co., Ltd. ever had a stock split?

Humedix Co., Ltd. had 5 splits and the recent split was on Dec 27, 2018.

Humedix Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
KRX SM Exchange
KR7200670008 ISIN
South Korea Country
- Employees
28 Aug 2026 Last Dividend
27 Dec 2018 Last Split
- IPO Date

Overview

Humedix Co., Ltd. is a significant player in the pharmaceutical industry, primarily operating within South Korea. The company's journey began in 2002, marking its foundation in an industry where innovation and quality are paramount. Initially known as HVLS Co., Ltd., the company underwent a strategic rebranding in 2010, adopting the name Humedix Co., Ltd. This rebranding reflected its broader vision and commitment to enhancing human health through its products. Humedix has established its headquarters in Seongnam-si, South Korea, from where it oversees its operations, including the manufacture and sale of a diverse range of pharmaceutical products. Its portfolio not only includes prescription medicines which are critical in treating various health conditions but also spans to active pharmaceutical ingredients essential for drug manufacturing. Furthermore, Humedix has expanded its offerings to encompass medical devices, cosmetics, and health functional food products, catering to a broad spectrum of healthcare and wellness needs. The company also specialises in the development and distribution of anticancer drugs, underscoring its role in advancing cancer treatment options.

Products and Services

  • Prescription Medicines
  • Humedix Co., Ltd. develops and markets a variety of prescription medicines aimed at treating various diseases and health conditions. These products are the backbone of the company's pharmaceutical offerings, ensuring patients receive the necessary medications for their health issues.

  • Active Pharmaceutical Ingredients (APIs)
  • The company is involved in the production of active pharmaceutical ingredients, which are crucial components in drug development and manufacturing. APIs from Humedix serve as the building blocks for many medications, highlighting their importance in the pharmaceutical supply chain.

  • Medical Devices
  • Humedix extends its expertise into the medical devices sector, offering products that aid in diagnosis, treatment, and patient care. These devices are integral to modern healthcare, providing essential functionalities to healthcare facilities and improving patient outcomes.

  • Cosmetics
  • Recognizing the growing demand for skincare and beauty products, Humedix has diversified its product range to include cosmetics. These products combine pharmaceutical knowledge with cosmetic needs, aiming to provide high-quality, effective skincare solutions.

  • Health Functional Food Products
  • The company also explores the intersection of nutrition and health by offering health functional food products. These products are designed to provide specific health benefits beyond basic nutrition, aligning with the increasing consumer focus on wellness and preventive health care.

  • Anticancer Drugs
  • Specializing in the manufacture and distribution of anticancer drugs, Humedix plays a pivotal role in the fight against cancer. These drugs represent a critical segment of the company's product portfolio, focusing on providing effective treatment options for cancer patients.

Contact Information

Address: HuonsGlobal Building
Phone: 82 70 7492 5600